SRPT Sarepta Therapeutics

Sarepta Therapeutics Inc shares fell 5.00 percent to $79.98 in intraday trading.

At 00:57 on October 19th, Beijing time, Sarepta Therapeutics Inc (SRPT.us) shares fluctuated and fell rapidly by 5.00%. As of press time, the stock was trading at US $79.98 per share, with a turnover of 887180 shares, a turnover rate of 1.11% and an amplitude of 5.71%. Recent earnings data show that the stock achieved operating income of $164 million, net profit of-81.41 million, earnings per share of-1.02, gross profit of $136 million, and price-to-earnings ratio of-9.94 times. In terms of agency rating

10-18 12:57 ET

Expert Ratings For Sarepta Therapeutics

Over the past 3 months, 6 analysts have published their opinion on Sarepta Therapeutics (NASDAQ:SRPT) stock. These analysts are typically employed by large Wall Street banks and tasked with understand

10-15 12:18 ET

Sarepta Therapeutics analyst ratings

DateResearch FirmActionCurrentPT 10/15/21Credit SuisseMaintainsNeutral95.0 10/12/21Credit SuisseMaintainsNeutral100.0 10/12/21BTIGMaintainsBuy125.0 9/15/21GuggenheimUpgradesBuy 8/16/21Morgan StanleyMa

10-15 07:50 ET

The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Editas Medicine, Sarepta Therapeutics and Beam Therapeutics

For Immediate ReleaseChicago, IL – October 15, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and even

10-15 07:47 ET

BRIEF-Sarepta Therapeutics Announces Pricing Of $500 Mln Public Offering Of Common Stock

Oct 13 (Reuters) - Sarepta Therapeutics Inc SRPT.O :* SAREPTA THERAPEUTICS ANNOUNCES PRICING OF $500 MILLION PUBLIC OFFERING OF COMMON STOCK* SAREPTA THERAPEUTICS INC - PRICED AN UNDERWRITTEN PUBLIC

10-13 21:20 ET

Calendar Of Equity Issues Expected To Price This Week

Initial Offerings: GitLab Inc. (GTLB)--10.40 million shares expected to price Wednesday via Goldman Sachs, J.P. Morgan Securities LLC and BofA Securities Inc. Price

10-13 12:02 ET

Sarepta Therapeutics Inc shares fell 7.64% in intraday trading.

At 21:32 on October 13, Beijing time, Sarepta Therapeutics Inc (SRPT.us) shares fluctuated and fell sharply by 7.64%. As of press time, the stock was trading at US $87.81 per share, with a turnover of 109867 shares, a turnover rate of 0.14% and an amplitude of 2.10%. Recent earnings data show that the stock achieved operating income of $164 million, net profit of-81.41 million, earnings per share of-1.02, gross profit of $136 million, and price-to-earnings ratio of-10.91 times. Agency rating party

10-13 09:32 ET

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  Gainers Revance Therapeutics (NASDAQ:RVNC) stock moved upwards by 17.79% to $24.09 during Wednesday's pre-market session. The company's market cap stands at $1.7 billion.NeuroBo Pharmaceuticals (NAS

10-13 08:12 ET

The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Revance Clarifies Gabellar Line Treatment Review On Track Responding to the public disclosure of its F

10-13 07:48 ET

A Peek Into The Markets: US Stock Futures Gain Ahead Of CPI, Fed Minutes

Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade after the Dow Jones dropped more than 100 points in the previous session. Investors are awaiting earnings results fr

10-13 06:22 ET